HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CHPA on bar codes

This article was originally published in The Tan Sheet

Executive Summary

Use of the UPC code to address medication errors will "result in significant barriers in distribution channels" if it changes code's current intended use or efficiency, CHPA says in July 12 comments to FDA. Responding to agency's request for input on whether all OTC, Rx drugs should carry bar codes, trade association says it is unsure whether "a bar code in addition to the UPC on the package is either feasible or that institutions will have the appropriate tools to read this code and convert the information into a usable format that will reduce medication errors." CHPA cites need to establish "well-developed, evidence-based description" of medication errors involving OTC use in institutional settings. Group will make more detailed remarks at July 26 meeting (1"The Tan Sheet" June 24, 2002, p. 4)...

You may also be interested in...

FDA Drug Bar Code Proposal Could Extend To OTCs

FDA will seek comment on whether all OTC and Rx drugs should carry bar codes during a public meeting in Bethesda, Md. July 26

Neuroscience Challenges Oncology For Top Spot In CDER’s 2019 Novel Approvals

Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.

In Case You Missed It … News On China Patents, EMA Chief, And More

We clean out your Martin Luther King Day inbox so you don't have to.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts